25 XP   0   0   10

Tianjin Zhongxin Pharmaceutical Group Corp Ltd
Buy, Hold or Sell?

Let's analyse Tianjin Zhongxin Pharmaceutical Group Corp Ltd together

PenkeI guess you are interested in Tianjin Zhongxin Pharmaceutical Group Corp Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tianjin Zhongxin Pharmaceutical Group Corp Ltd

I send you an email if I find something interesting about Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

Quick analysis of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (30 sec.)










What can you expect buying and holding a share of Tianjin Zhongxin Pharmaceutical Group Corp Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.16
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥11.66
Expected worth in 1 year
¥14.84
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
¥4.33
Return On Investment
13.1%

For what price can you sell your share?

Current Price per Share
¥33.12
Expected price per share
¥27.53 - ¥36.56
How sure are you?
50%

1. Valuation of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (5 min.)




Live pricePrice per Share (EOD)

¥33.12

Intrinsic Value Per Share

¥16.63 - ¥46.68

Total Value Per Share

¥28.28 - ¥58.33

2. Growth of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (5 min.)




Is Tianjin Zhongxin Pharmaceutical Group Corp Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$918.3m$923.4m-$8.3m-0.9%

How much money is Tianjin Zhongxin Pharmaceutical Group Corp Ltd making?

Current yearPrevious yearGrowGrow %
Making money$34m$29.7m$4.3m12.7%
Net Profit Margin12.1%11.1%--

How much money comes from the company's main activities?

3. Financial Health of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (5 min.)




What can you expect buying and holding a share of Tianjin Zhongxin Pharmaceutical Group Corp Ltd? (5 min.)

Welcome investor! Tianjin Zhongxin Pharmaceutical Group Corp Ltd's management wants to use your money to grow the business. In return you get a share of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

What can you expect buying and holding a share of Tianjin Zhongxin Pharmaceutical Group Corp Ltd?

First you should know what it really means to hold a share of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is ¥33.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tianjin Zhongxin Pharmaceutical Group Corp Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥11.66. Based on the TTM, the Book Value Change Per Share is ¥0.80 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.29 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.1%0.050.1%0.050.2%0.040.1%0.030.1%
Usd Book Value Change Per Share0.441.3%0.110.3%0.000.0%0.030.1%0.020.1%
Usd Dividend Per Share0.000.0%0.040.1%0.020.1%0.020.1%0.020.1%
Usd Total Gains Per Share0.441.3%0.150.5%0.020.1%0.050.2%0.040.1%
Usd Price Per Share4.65-5.37-3.54-3.36-2.85-
Price to Earnings Ratio37.32-33.84-18.48-24.10-23.92-
Price-to-Total Gains Ratio10.50-100.76-42.07-14.90-49.53-
Price to Book Ratio2.89-4.28-2.97-2.94-2.76-
Price-to-Total Gains Ratio10.50-100.76-42.07-14.90-49.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.577184
Number of shares218
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.02
Usd Book Value Change Per Share0.110.03
Usd Total Gains Per Share0.150.05
Gains per Quarter (218 shares)32.5811.77
Gains per Year (218 shares)130.3347.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13496120173037
269192250336184
31032883805091131
413838451067122178
517248064083152225
6206576770100183272
7241671900116213319
82757671030133244366
93108631160150274413
103449591290166304460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%74.00.04.094.9%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%33.07.00.082.5%60.018.00.076.9%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%72.00.06.092.3%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%37.03.00.092.5%70.08.00.089.7%

Fundamentals of Tianjin Zhongxin Pharmaceutical Group Corp Ltd

About Tianjin Zhongxin Pharmaceutical Group Corp Ltd

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was founded in 1981 and is based in Tianjin, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-17 06:50:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tianjin Zhongxin Pharmaceutical Group Corp Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 5.3% means that ¥0.05 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 5.3%. The company is making a profit. +1
  • The TTM is 12.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ5.3%TTM12.1%-6.8%
TTM12.1%YOY11.1%+1.0%
TTM12.1%5Y10.6%+1.5%
5Y10.6%10Y8.9%+1.8%
1.1.2. Return on Assets

Shows how efficient Tianjin Zhongxin Pharmaceutical Group Corp Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.3% Return on Assets means that Tianjin Zhongxin Pharmaceutical Group Corp Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM2.3%-1.1%
TTM2.3%YOY2.3%+0.1%
TTM2.3%5Y2.2%+0.2%
5Y2.2%10Y2.0%+0.2%
1.1.3. Return on Equity

Shows how efficient Tianjin Zhongxin Pharmaceutical Group Corp Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.9% Return on Equity means Tianjin Zhongxin Pharmaceutical Group Corp Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 1.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.9%TTM3.7%-1.8%
TTM3.7%YOY3.3%+0.5%
TTM3.7%5Y3.2%+0.5%
5Y3.2%10Y3.1%+0.1%

1.2. Operating Efficiency of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tianjin Zhongxin Pharmaceutical Group Corp Ltd is operating .

  • Measures how much profit Tianjin Zhongxin Pharmaceutical Group Corp Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM7.3%-7.3%
TTM7.3%YOY8.5%-1.2%
TTM7.3%5Y8.6%-1.4%
5Y8.6%10Y4.8%+3.8%
1.2.2. Operating Ratio

Measures how efficient Tianjin Zhongxin Pharmaceutical Group Corp Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.54 means that the operating costs are ¥1.54 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 1.536. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.454. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.536TTM1.454+0.082
TTM1.454YOY1.505-0.051
TTM1.4545Y1.499-0.045
5Y1.49910Y1.142+0.357

1.3. Liquidity of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tianjin Zhongxin Pharmaceutical Group Corp Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.03 means the company has ¥2.03 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 2.027. The company is able to pay all its short-term debts. +1
  • The TTM is 2.024. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.027TTM2.024+0.002
TTM2.024YOY2.503-0.479
TTM2.0245Y2.377-0.352
5Y2.37710Y1.359+1.018
1.3.2. Quick Ratio

Measures if Tianjin Zhongxin Pharmaceutical Group Corp Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.67 means the company can pay off ¥0.67 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 0.672. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.754. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.672TTM0.754-0.082
TTM0.754YOY0.945-0.192
TTM0.7545Y0.899-0.145
5Y0.89910Y0.835+0.064

1.4. Solvency of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tianjin Zhongxin Pharmaceutical Group Corp Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.35 means that Tianjin Zhongxin Pharmaceutical Group Corp Ltd assets are financed with 35.0% credit (debt) and the remaining percentage (100% - 35.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 0.350. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.366. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.350TTM0.366-0.015
TTM0.366YOY0.305+0.060
TTM0.3665Y0.311+0.054
5Y0.31110Y0.336-0.025
1.4.2. Debt to Equity Ratio

Measures if Tianjin Zhongxin Pharmaceutical Group Corp Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 54.3% means that company has ¥0.54 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The MRQ is 0.543. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.581. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.543TTM0.581-0.038
TTM0.581YOY0.449+0.131
TTM0.5815Y0.464+0.117
5Y0.46410Y0.538-0.074

2. Market Valuation of Tianjin Zhongxin Pharmaceutical Group Corp Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Tianjin Zhongxin Pharmaceutical Group Corp Ltd generates.

  • Above 15 is considered overpriced but always compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 37.32 means the investor is paying ¥37.32 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The EOD is 36.734. Based on the earnings, the company is overpriced. -1
  • The MRQ is 37.322. Based on the earnings, the company is overpriced. -1
  • The TTM is 33.843. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.734MRQ37.322-0.588
MRQ37.322TTM33.843+3.479
TTM33.843YOY18.481+15.362
TTM33.8435Y24.100+9.744
5Y24.10010Y23.918+0.182
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The EOD is 8.583. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.720. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -38.823. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.583MRQ8.720-0.137
MRQ8.720TTM-38.823+47.543
TTM-38.823YOY599.220-638.043
TTM-38.8235Y156.802-195.625
5Y156.80210Y78.207+78.595
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

  • The EOD is 2.842. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.887. Based on the equity, the company is underpriced. +1
  • The TTM is 4.278. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.842MRQ2.887-0.045
MRQ2.887TTM4.278-1.390
TTM4.278YOY2.969+1.308
TTM4.2785Y2.945+1.333
5Y2.94510Y2.764+0.180
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tianjin Zhongxin Pharmaceutical Group Corp Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.1940.796+301%0.012+25818%0.253+1164%0.178+1690%
Book Value Per Share--11.6559.344+25%8.639+35%8.114+44%7.428+57%
Current Ratio--2.0272.024+0%2.503-19%2.377-15%1.359+49%
Debt To Asset Ratio--0.3500.366-4%0.305+15%0.311+13%0.336+4%
Debt To Equity Ratio--0.5430.581-6%0.449+21%0.464+17%0.538+1%
Dividend Per Share--0.0110.285-96%0.125-91%0.138-92%0.129-91%
Eps--0.2250.334-33%0.365-38%0.273-18%0.232-3%
Free Cash Flow Per Share--0.9650.240+302%0.184+424%0.180+436%0.187+415%
Free Cash Flow To Equity Per Share--0.9650.128+654%0.171+466%0.101+856%0.195+395%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--46.677--------
Intrinsic Value_10Y_min--16.630--------
Intrinsic Value_1Y_max--1.419--------
Intrinsic Value_1Y_min--0.911--------
Intrinsic Value_3Y_max--6.747--------
Intrinsic Value_3Y_min--3.407--------
Intrinsic Value_5Y_max--15.069--------
Intrinsic Value_5Y_min--6.619--------
Market Cap18883633489.920-2%19185817238.40028265479814.590-32%19804009960.980-3%18418363944.302+4%14294359385.589+34%
Net Profit Margin--0.0530.121-56%0.111-52%0.106-50%0.089-40%
Operating Margin---0.073-100%0.085-100%0.086-100%0.048-100%
Operating Ratio--1.5361.454+6%1.505+2%1.499+2%1.142+35%
Pb Ratio2.842-2%2.8874.278-33%2.969-3%2.945-2%2.764+4%
Pe Ratio36.734-2%37.32233.843+10%18.481+102%24.100+55%23.918+56%
Price Per Share33.120-2%33.65038.840-13%25.605+31%24.302+38%20.650+63%
Price To Free Cash Flow Ratio8.583-2%8.720-38.823+545%599.220-99%156.802-94%78.207-89%
Price To Total Gains Ratio10.333-2%10.499100.765-90%42.067-75%14.902-30%49.527-79%
Quick Ratio--0.6720.754-11%0.945-29%0.899-25%0.835-19%
Return On Assets--0.0130.023-46%0.023-44%0.022-42%0.020-37%
Return On Equity--0.0190.037-48%0.033-41%0.032-40%0.031-37%
Total Gains Per Share--3.2051.081+196%0.137+2231%0.391+720%0.308+942%
Usd Book Value--918371685.285915051286.148+0%923402812.792-1%848997604.995+8%703403010.651+31%
Usd Book Value Change Per Share--0.4410.110+301%0.002+25818%0.035+1164%0.025+1690%
Usd Book Value Per Share--1.6111.291+25%1.194+35%1.121+44%1.027+57%
Usd Dividend Per Share--0.0020.039-96%0.017-91%0.019-92%0.018-91%
Usd Eps--0.0310.046-33%0.050-38%0.038-18%0.032-3%
Usd Free Cash Flow--76013385.96118918203.903+302%19670809.488+286%17858816.403+326%15884242.683+379%
Usd Free Cash Flow Per Share--0.1330.033+302%0.025+424%0.025+436%0.026+415%
Usd Free Cash Flow To Equity Per Share--0.1330.018+654%0.024+466%0.014+856%0.027+395%
Usd Market Cap2609718148.307-2%2651479942.3473906289310.376-32%2736914176.607-3%2545417897.103+4%1975480467.088+34%
Usd Price Per Share4.577-2%4.6505.368-13%3.539+31%3.359+38%2.854+63%
Usd Profit--17760828.92334090739.904-48%29774979.481-40%26982988.173-34%21332361.946-17%
Usd Revenue--335725399.368284080874.385+18%285011572.477+18%255508578.136+31%239680756.514+40%
Usd Total Gains Per Share--0.4430.149+196%0.019+2231%0.054+720%0.043+942%
 EOD+4 -4MRQTTM+18 -17YOY+15 -205Y+18 -1710Y+18 -17

3.2. Fundamental Score

Let's check the fundamental score of Tianjin Zhongxin Pharmaceutical Group Corp Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.734
Price to Book Ratio (EOD)Between0-12.842
Net Profit Margin (MRQ)Greater than00.053
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.672
Current Ratio (MRQ)Greater than12.027
Debt to Asset Ratio (MRQ)Less than10.350
Debt to Equity Ratio (MRQ)Less than10.543
Return on Equity (MRQ)Greater than0.150.019
Return on Assets (MRQ)Greater than0.050.013
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Tianjin Zhongxin Pharmaceutical Group Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.327
Ma 20Greater thanMa 5030.383
Ma 50Greater thanMa 10029.540
Ma 100Greater thanMa 20031.436
OpenGreater thanClose32.900
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets10,230,101
Total Liabilities3,584,864
Total Stockholder Equity6,600,691
 As reported
Total Liabilities 3,584,864
Total Stockholder Equity+ 6,600,691
Total Assets = 10,230,101

Assets

Total Assets10,230,101
Total Current Assets6,551,674
Long-term Assets3,678,427
Total Current Assets
Cash And Cash Equivalents 2,125,200
Net Receivables 2,172,700
Inventory 1,566,518
Other Current Assets 97,310
Total Current Assets  (as reported)6,551,674
Total Current Assets  (calculated)5,961,728
+/- 589,947
Long-term Assets
Property Plant Equipment 1,441,511
Goodwill 65,911
Intangible Assets 330,825
Long-term Assets Other 673,262
Long-term Assets  (as reported)3,678,427
Long-term Assets  (calculated)2,511,510
+/- 1,166,917

Liabilities & Shareholders' Equity

Total Current Liabilities3,232,922
Long-term Liabilities351,942
Total Stockholder Equity6,600,691
Total Current Liabilities
Short Long Term Debt 81,800
Accounts payable 1,126,091
Other Current Liabilities 27,901
Total Current Liabilities  (as reported)3,232,922
Total Current Liabilities  (calculated)1,235,792
+/- 1,997,131
Long-term Liabilities
Long term Debt 241,035
Capital Lease Obligations Min Short Term Debt2,743
Long-term Liabilities  (as reported)351,942
Long-term Liabilities  (calculated)243,778
+/- 108,165
Total Stockholder Equity
Retained Earnings 4,391,271
Total Stockholder Equity (as reported)6,600,691
Total Stockholder Equity (calculated)4,391,271
+/- 2,209,419
Other
Capital Stock770,158
Common Stock Shares Outstanding 400,000
Net Invested Capital 6,923,525
Net Working Capital 3,318,752
Property Plant and Equipment Gross 1,441,511



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-31
> Total Assets 
3,858,605
3,966,159
3,935,690
3,836,730
3,863,101
3,920,211
3,954,958
4,031,937
3,983,829
3,994,075
3,916,437
3,555,228
3,738,919
3,633,411
3,577,640
3,478,678
3,408,609
3,384,877
3,369,458
3,444,939
3,578,494
3,624,670
3,667,035
3,825,379
3,791,124
3,804,532
3,836,486
4,138,300
4,388,197
4,152,578
4,143,615
4,384,489
4,443,643
4,271,797
4,420,497
4,697,264
4,697,342
4,599,836
5,262,332
5,150,299
5,255,940
5,259,529
5,437,207
5,685,448
6,418,046
6,141,305
6,068,877
6,292,839
6,252,739
6,205,578
6,360,678
6,415,369
6,830,792
6,788,495
6,621,805
6,891,575
7,017,814
7,092,170
7,105,306
7,462,270
7,569,840
7,554,489
7,843,177
8,054,875
8,097,131
8,010,839
8,283,388
8,801,325
8,999,122
9,125,217
9,067,085
9,315,345
9,290,069
9,749,984
10,156,982
10,866,528
10,364,006
10,281,701
10,230,101
10,230,10110,281,70110,364,00610,866,52810,156,9829,749,9849,290,0699,315,3459,067,0859,125,2178,999,1228,801,3258,283,3888,010,8398,097,1318,054,8757,843,1777,554,4897,569,8407,462,2707,105,3067,092,1707,017,8146,891,5756,621,8056,788,4956,830,7926,415,3696,360,6786,205,5786,252,7396,292,8396,068,8776,141,3056,418,0465,685,4485,437,2075,259,5295,255,9405,150,2995,262,3324,599,8364,697,3424,697,2644,420,4974,271,7974,443,6434,384,4894,143,6154,152,5784,388,1974,138,3003,836,4863,804,5323,791,1243,825,3793,667,0353,624,6703,578,4943,444,9393,369,4583,384,8773,408,6093,478,6783,577,6403,633,4113,738,9193,555,2283,916,4373,994,0753,983,8294,031,9373,954,9583,920,2113,863,1013,836,7303,935,6903,966,1593,858,605
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,548,111
4,673,908
4,780,038
5,040,598
4,990,029
5,019,151
5,134,751
5,318,660
5,293,625
5,357,729
5,603,602
6,097,664
6,310,897
6,519,417
6,424,994
6,614,108
6,673,101
6,915,033
7,245,445
7,903,764
6,792,990
6,707,646
6,551,674
6,551,6746,707,6466,792,9907,903,7647,245,4456,915,0336,673,1016,614,1086,424,9946,519,4176,310,8976,097,6645,603,6025,357,7295,293,6255,318,6605,134,7515,019,1514,990,0295,040,5984,780,0384,673,9084,548,11100000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,200,742
1,211,710
1,467,085
1,477,899
1,012,788
1,342,284
1,479,441
1,600,610
1,510,626
1,285,869
1,987,334
2,090,718
2,103,643
2,147,959
2,283,181
2,694,279
2,596,936
2,349,095
2,882,524
3,455,307
2,103,958
2,019,893
2,125,200
2,125,2002,019,8932,103,9583,455,3072,882,5242,349,0952,596,9362,694,2792,283,1812,147,9592,103,6432,090,7181,987,3341,285,8691,510,6261,600,6101,479,4411,342,2841,012,7881,477,8991,467,0851,211,7101,200,74200000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,000
0
0
54,097
333,773
55,715
43,525
35,995
30,067
500,534
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000500,53430,06735,99543,52555,715333,77354,0970030,00000000000000000000000000000000000000000000000000000000000
       Net Receivables 
623,761
644,631
667,344
664,026
687,592
651,160
760,540
639,583
641,339
700,994
667,980
430,775
524,100
527,550
472,729
515,805
591,348
604,438
626,973
520,214
713,970
805,200
689,562
736,429
676,056
719,934
698,892
839,561
829,864
947,425
884,339
1,082,666
1,052,848
1,163,765
1,161,358
1,249,811
1,281,025
1,380,281
1,648,985
1,485,956
1,421,012
1,276,202
1,693,613
1,592,296
1,513,041
1,587,236
1,538,956
1,635,867
1,674,164
1,645,974
1,465,777
1,570,628
1,645,088
1,667,909
1,541,127
1,689,530
1,758,351
1,788,231
1,728,509
1,586,111
1,637,724
1,656,540
1,808,588
2,157,137
2,127,871
2,039,660
2,007,425
2,433,374
2,568,365
2,413,758
2,011,319
2,336,026
2,659,223
3,114,608
2,146,213
2,813,720
2,850,477
2,598,194
2,172,700
2,172,7002,598,1942,850,4772,813,7202,146,2133,114,6082,659,2232,336,0262,011,3192,413,7582,568,3652,433,3742,007,4252,039,6602,127,8712,157,1371,808,5881,656,5401,637,7241,586,1111,728,5091,788,2311,758,3511,689,5301,541,1271,667,9091,645,0881,570,6281,465,7771,645,9741,674,1641,635,8671,538,9561,587,2361,513,0411,592,2961,693,6131,276,2021,421,0121,485,9561,648,9851,380,2811,281,0251,249,8111,161,3581,163,7651,052,8481,082,666884,339947,425829,864839,561698,892719,934676,056736,429689,562805,200713,970520,214626,973604,438591,348515,805472,729527,550524,100430,775667,980700,994641,339639,583760,540651,160687,592664,026667,344644,631623,761
       Other Current Assets 
0
0
0
43,793
0
0
0
91,467
59,213
52,855
75,438
75,870
70,287
87,671
87,628
54,018
57,899
42,990
41,606
63,277
39,321
55,356
70,372
116,430
123,259
120,686
97,566
63,827
109,848
74,972
135,767
100,839
155,471
158,761
146,295
157,323
220,980
107,706
125,752
258,374
373,070
313,630
197,530
206,690
336,327
378,933
175,808
490,942
201,502
162,228
163,609
741,131
230,001
314,833
222,260
289,788
334,419
274,457
202,766
61,864
74,527
59,914
208,640
151,353
146,606
99,850
121,128
152,215
116,855
556,712
495,769
171,577
125,277
107,463
76,822
171,102
99,933
70,692
97,310
97,31070,69299,933171,10276,822107,463125,277171,577495,769556,712116,855152,215121,12899,850146,606151,353208,64059,91474,52761,864202,766274,457334,419289,788222,260314,833230,001741,131163,609162,228201,502490,942175,808378,933336,327206,690197,530313,630373,070258,374125,752107,706220,980157,323146,295158,761155,471100,839135,76774,972109,84863,82797,566120,686123,259116,43070,37255,35639,32163,27741,60642,99057,89954,01887,62887,67170,28775,87075,43852,85559,21391,46700043,793000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,421,672
2,579,811
2,535,338
2,708,426
2,736,214
2,803,506
2,653,109
2,679,785
2,703,661
2,688,225
2,605,800
2,642,091
2,701,237
2,616,967
2,834,951
2,911,537
2,962,764
3,571,015
3,574,055
3,678,427
3,678,4273,574,0553,571,0152,962,7642,911,5372,834,9512,616,9672,701,2372,642,0912,605,8002,688,2252,703,6612,679,7852,653,1092,803,5062,736,2142,708,4262,535,3382,579,8112,421,67200000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
1,693,587
1,752,955
1,780,523
1,762,622
1,772,979
1,789,339
1,793,876
1,821,137
1,431,486
1,416,404
1,407,321
1,586,449
1,359,595
1,346,916
1,339,182
1,225,547
1,217,946
1,192,428
1,174,200
1,156,466
1,138,131
1,129,192
1,136,174
1,120,029
1,098,400
1,098,821
1,141,284
1,131,007
1,123,599
1,112,806
1,105,206
1,087,039
969,824
905,446
909,376
900,122
890,327
893,159
886,216
870,142
858,684
890,211
870,231
877,271
876,081
890,355
921,476
925,963
924,270
948,222
982,240
973,166
1,016,357
1,037,314
1,075,695
1,088,574
1,109,178
1,146,949
1,199,669
1,206,096
1,210,870
1,248,411
1,367,398
1,400,847
1,402,534
1,422,288
1,459,662
1,456,032
1,478,281
1,501,299
1,486,326
1,497,523
1,452,964
1,471,611
1,464,588
1,447,053
1,432,372
1,423,330
1,441,511
1,441,5111,423,3301,432,3721,447,0531,464,5881,471,6111,452,9641,497,5231,486,3261,501,2991,478,2811,456,0321,459,6621,422,2881,402,5341,400,8471,367,3981,248,4111,210,8701,206,0961,199,6691,146,9491,109,1781,088,5741,075,6951,037,3141,016,357973,166982,240948,222924,270925,963921,476890,355876,081877,271870,231890,211858,684870,142886,216893,159890,327900,122909,376905,446969,8241,087,0391,105,2061,112,8061,123,5991,131,0071,141,2841,098,8211,098,4001,120,0291,136,1741,129,1921,138,1311,156,4661,174,2001,192,4281,217,9461,225,5471,339,1821,346,9161,359,5951,586,4491,407,3211,416,4041,431,4861,821,1371,793,8761,789,3391,772,9791,762,6221,780,5231,752,9551,693,587
       Goodwill 
0
0
0
0
0
0
0
0
918
887
856
0
0
0
0
0
0
983
983
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,851
1,851
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,168
84,693
84,693
84,693
84,693
65,911
65,91184,69384,69384,69384,69398,16800000000000000000001,8511,85100000000000000000000000000000000098398300000085688791800000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
786,287
922,709
773,011
863,870
946,278
852,926
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000852,926946,278863,870773,011922,709786,28700000000000000000000000000000000000000000000000000000000
       Intangible Assets 
8,921
10,574
11,201
10,522
8,714
9,631
8,800
18,927
241,636
243,732
241,932
19,255
234,607
232,233
230,143
171,967
194,023
195,074
193,237
190,248
188,409
198,614
199,468
197,682
198,058
196,133
203,011
201,136
199,631
198,579
198,418
196,489
191,665
179,218
177,948
176,289
174,657
173,082
197,062
195,636
193,977
169,115
191,015
189,876
188,675
187,067
185,597
182,633
183,170
181,240
177,360
176,039
178,520
177,935
178,066
176,703
175,486
174,120
173,527
173,311
14,800
174,397
175,572
180,582
178,671
177,146
204,023
202,292
200,544
201,462
202,908
203,664
229,017
294,787
292,130
343,130
342,723
337,998
330,825
330,825337,998342,723343,130292,130294,787229,017203,664202,908201,462200,544202,292204,023177,146178,671180,582175,572174,39714,800173,311173,527174,120175,486176,703178,066177,935178,520176,039177,360181,240183,170182,633185,597187,067188,675189,876191,015169,115193,977195,636197,062173,082174,657176,289177,948179,218191,665196,489198,418198,579199,631201,136203,011196,133198,058197,682199,468198,614188,409190,248193,237195,074194,023171,967230,143232,233234,60719,255241,932243,732241,63618,9278,8009,6318,71410,52211,20110,5748,921
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,965
137,480
150,851
151,710
129,674
139,081
1,547,110
125,923
131,161
22,733
23,538
34,743
15,247
15,477
22,965
39,674
38,293
39,067
40,478
673,262
673,26240,47839,06738,29339,67422,96515,47715,24734,74323,53822,733131,161125,9231,547,110139,081129,674151,710150,851137,48053,96500000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
2,076,965
2,199,193
2,149,718
2,037,065
2,034,536
2,117,612
2,138,164
2,113,071
2,105,727
2,152,335
2,085,390
2,107,698
2,200,370
2,036,608
1,985,847
2,145,102
2,039,520
1,931,520
1,903,248
1,972,235
1,997,796
1,885,492
1,878,903
1,916,726
1,815,300
1,771,008
1,749,568
1,924,070
2,220,908
1,939,335
1,938,555
2,023,670
2,121,425
1,908,925
2,141,725
2,297,360
2,230,747
2,076,864
2,687,367
2,466,144
2,506,685
2,430,461
2,490,571
2,608,564
2,515,838
2,171,557
1,963,703
2,089,962
2,032,434
1,896,320
2,058,390
1,982,377
2,380,500
2,260,051
1,996,314
2,130,877
2,273,555
2,261,790
2,050,909
2,208,590
2,327,423
2,216,636
2,319,971
2,361,787
2,474,081
2,233,693
2,333,494
2,632,114
2,813,340
2,740,713
2,553,256
2,612,227
2,694,575
2,873,984
3,605,029
3,933,821
3,974,357
3,764,451
3,584,864
3,584,8643,764,4513,974,3573,933,8213,605,0292,873,9842,694,5752,612,2272,553,2562,740,7132,813,3402,632,1142,333,4942,233,6932,474,0812,361,7872,319,9712,216,6362,327,4232,208,5902,050,9092,261,7902,273,5552,130,8771,996,3142,260,0512,380,5001,982,3772,058,3901,896,3202,032,4342,089,9621,963,7032,171,5572,515,8382,608,5642,490,5712,430,4612,506,6852,466,1442,687,3672,076,8642,230,7472,297,3602,141,7251,908,9252,121,4252,023,6701,938,5551,939,3352,220,9081,924,0701,749,5681,771,0081,815,3001,916,7261,878,9031,885,4921,997,7961,972,2351,903,2481,931,5202,039,5202,145,1021,985,8472,036,6082,200,3702,107,6982,085,3902,152,3352,105,7272,113,0712,138,1642,117,6122,034,5362,037,0652,149,7182,199,1932,076,965
   > Total Current Liabilities 
1,927,921
2,076,949
2,027,474
1,928,512
2,022,062
2,094,128
2,106,431
1,722,922
1,603,349
1,649,965
1,583,531
1,552,376
1,637,864
1,573,941
1,523,614
1,984,042
1,945,383
1,846,595
1,807,695
1,936,572
1,857,521
1,740,331
1,723,772
1,754,242
1,611,857
1,571,116
1,532,625
1,806,510
2,136,356
1,857,238
1,869,590
1,954,642
2,052,861
1,850,465
2,084,930
2,240,929
2,174,228
2,018,267
2,607,749
2,387,111
2,429,006
2,293,473
2,361,946
2,477,145
2,383,870
2,043,100
1,840,323
1,957,448
1,897,516
1,762,188
1,928,513
1,852,783
2,250,336
2,123,396
1,861,462
1,994,610
2,136,930
2,125,036
1,914,063
2,072,514
2,189,453
2,051,045
2,157,207
2,198,840
2,315,200
2,071,369
2,163,851
2,463,060
2,646,859
2,603,399
2,433,902
2,495,575
2,558,150
2,680,520
3,333,435
3,560,726
3,613,343
3,403,691
3,232,922
3,232,9223,403,6913,613,3433,560,7263,333,4352,680,5202,558,1502,495,5752,433,9022,603,3992,646,8592,463,0602,163,8512,071,3692,315,2002,198,8402,157,2072,051,0452,189,4532,072,5141,914,0632,125,0362,136,9301,994,6101,861,4622,123,3962,250,3361,852,7831,928,5131,762,1881,897,5161,957,4481,840,3232,043,1002,383,8702,477,1452,361,9462,293,4732,429,0062,387,1112,607,7492,018,2672,174,2282,240,9292,084,9301,850,4652,052,8611,954,6421,869,5901,857,2382,136,3561,806,5101,532,6251,571,1161,611,8571,754,2421,723,7721,740,3311,857,5211,936,5721,807,6951,846,5951,945,3831,984,0421,523,6141,573,9411,637,8641,552,3761,583,5311,649,9651,603,3491,722,9222,106,4312,094,1282,022,0621,928,5122,027,4742,076,9491,927,921
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
202,000
52,000
52,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000052,00052,000202,00000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
202,000
52,000
52,000
0
0
0
0
0
0
0
0
0
0
0
43,107
101,639
351,277
530,169
530,169
81,800
81,800530,169530,169351,277101,63943,1070000000000052,00052,000202,00000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
625,067
579,286
574,049
471,786
478,540
453,892
463,660
586,158
609,740
583,612
602,236
625,606
643,340
605,886
503,797
474,266
361,300
318,458
446,466
436,461
436,255
507,878
554,664
501,844
471,651
427,621
425,295
550,543
553,208
545,868
534,010
637,020
593,332
652,438
606,060
678,442
661,885
638,038
657,887
667,505
687,155
1,266,028
759,481
719,749
864,379
877,425
704,823
789,131
774,892
770,549
730,098
668,601
778,890
764,113
647,643
628,715
614,810
674,573
594,809
665,285
613,239
649,889
611,727
640,044
693,724
667,377
894,639
1,153,222
1,149,079
1,270,872
1,242,499
1,151,729
1,079,728
1,191,817
1,405,890
1,281,299
1,127,572
1,008,175
1,126,091
1,126,0911,008,1751,127,5721,281,2991,405,8901,191,8171,079,7281,151,7291,242,4991,270,8721,149,0791,153,222894,639667,377693,724640,044611,727649,889613,239665,285594,809674,573614,810628,715647,643764,113778,890668,601730,098770,549774,892789,131704,823877,425864,379719,749759,4811,266,028687,155667,505657,887638,038661,885678,442606,060652,438593,332637,020534,010545,868553,208550,543425,295427,621471,651501,844554,664507,878436,255436,461446,466318,458361,300474,266503,797605,886643,340625,606602,236583,612609,740586,158463,660453,892478,540471,786574,049579,286625,067
       Other Current Liabilities 
16,324
77,133
44,895
230,806
9,402
35,316
10,851
233,144
213,608
276,353
230,375
231,770
277,524
290,055
446,817
539,776
1,034,083
489,137
685,229
568,611
593,896
419,453
391,107
435,897
422,206
475,495
453,330
465,967
637,148
468,370
500,745
504,787
557,694
518,027
604,870
580,487
637,342
480,229
660,662
640,405
730,852
17,845
680,764
746,296
687,891
708,974
599,850
697,208
739,332
597,139
622,925
673,037
906,050
764,998
717,461
1,073,895
557,417
1,077,376
537,176
226,176
225,556
1,210
681,751
1,421,759
646,415
1,257,185
551,435
1,158,838
566,565
1,158,893
480,031
1,138,096
502,510
1,255,792
173
1,690,758
539,943
6,920
27,901
27,9016,920539,9431,690,7581731,255,792502,5101,138,096480,0311,158,893566,5651,158,838551,4351,257,185646,4151,421,759681,7511,210225,556226,176537,1761,077,376557,4171,073,895717,461764,998906,050673,037622,925597,139739,332697,208599,850708,974687,891746,296680,76417,845730,852640,405660,662480,229637,342580,487604,870518,027557,694504,787500,745468,370637,148465,967453,330475,495422,206435,897391,107419,453593,896568,611685,229489,1371,034,083539,776446,817290,055277,524231,770230,375276,353213,608233,14410,85135,3169,402230,80644,89577,13316,324
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
136,077
137,971
165,592
162,764
162,947
158,881
162,323
169,642
169,055
166,481
137,313
119,354
116,653
136,424
193,464
271,594
373,095
361,014
360,760
351,942
351,942360,760361,014373,095271,594193,464136,424116,653119,354137,313166,481169,055169,642162,323158,881162,947162,764165,592137,971136,07700000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-202,000
-48,581
-48,620
2,710
2,206
2,165
1,703
1,710
1,223
1,204
673
1,572
804
849
1,057
871
582
608
597
2,743
2,7435976085828711,0578498041,5726731,2041,2231,7101,7032,1652,2062,710-48,620-48,581-202,00000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,419
32,805
32,710
32,206
32,165
40,122
0
40,802
0
41,978
41,978
40,638
0
45,370
0
40,638
0
39,488
0
039,488040,638045,370040,63841,97841,978040,802040,12232,16532,20632,71032,8053,419000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,016
6,389
9,988
9,149
9,171
8,709
8,290
7,623
6,971
6,202
8,811
8,156
7,501
9,695
12,311
14,038
15,347
20,576
0
17,003
18,503
0
0
0018,50317,003020,57615,34714,03812,3119,6957,5018,1568,8116,2026,9717,6238,2908,7099,1719,1499,9886,3895,01600000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,537,203
1,514,364
1,525,142
1,526,229
1,550,726
1,517,437
1,527,965
1,590,928
1,658,540
1,624,625
1,613,390
1,216,170
1,306,497
1,360,893
1,353,963
1,098,964
1,133,149
1,216,648
1,233,495
1,235,665
1,339,544
1,472,002
1,519,637
1,631,904
1,693,827
1,744,935
1,799,728
1,917,714
1,843,799
1,888,390
1,882,616
2,032,677
2,164,518
2,212,863
2,136,896
2,254,582
2,320,592
2,372,141
2,417,381
2,520,600
2,579,230
2,649,977
2,763,777
2,894,065
3,721,591
3,788,691
3,921,708
4,028,506
4,049,956
4,144,763
4,139,629
4,275,597
4,294,632
4,377,508
4,476,758
4,633,128
4,620,860
4,706,074
4,926,990
5,124,697
5,108,016
5,204,216
5,388,174
5,558,148
5,482,881
5,635,552
5,808,409
6,023,857
6,043,844
6,237,126
6,364,478
6,565,524
6,451,363
6,706,827
6,521,461
6,905,220
6,332,315
6,468,059
6,600,691
6,600,6916,468,0596,332,3156,905,2206,521,4616,706,8276,451,3636,565,5246,364,4786,237,1266,043,8446,023,8575,808,4095,635,5525,482,8815,558,1485,388,1745,204,2165,108,0165,124,6974,926,9904,706,0744,620,8604,633,1284,476,7584,377,5084,294,6324,275,5974,139,6294,144,7634,049,9564,028,5063,921,7083,788,6913,721,5912,894,0652,763,7772,649,9772,579,2302,520,6002,417,3812,372,1412,320,5922,254,5822,136,8962,212,8632,164,5182,032,6771,882,6161,888,3901,843,7991,917,7141,799,7281,744,9351,693,8271,631,9041,519,6371,472,0021,339,5441,235,6651,233,4951,216,6481,133,1491,098,9641,353,9631,360,8931,306,4971,216,1701,613,3901,624,6251,658,5401,590,9281,527,9651,517,4371,550,7261,526,2291,525,1421,514,3641,537,203
   Common Stock
0
0
0
369,654
0
0
0
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
369,654
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,309
739,308
739,309
739,309
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
768,873
772,803
772,803
772,803
773,743
773,643
773,643
773,643
773,643
773,443
773,443
773,443
773,443
0
773,443
770,250
0
0
00770,250773,4430773,443773,443773,443773,443773,643773,643773,643773,643773,743772,803772,803772,803768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873768,873739,309739,309739,308739,309739,309739,309739,309739,309739,309739,309739,309739,309739,309739,309739,309739,309739,309739,309739,309369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654369,654000369,654000
   Retained Earnings 
217,565
194,726
205,504
195,304
219,801
185,513
196,041
221,533
355,983
322,070
310,835
0
0
0
0
0
0
0
0
0
0
110,489
155,695
267,331
343,465
399,302
448,982
566,596
496,088
548,669
548,770
696,773
869,588
920,014
841,851
960,317
1,031,046
1,078,671
1,119,585
1,221,926
1,280,947
1,174,062
1,440,420
1,559,586
1,568,143
1,664,310
1,780,653
1,900,235
1,923,967
2,014,595
2,010,858
2,144,606
2,161,164
2,243,166
2,344,433
2,517,801
2,504,150
2,591,565
2,752,338
2,507,981
2,495,685
2,593,887
3,208,755
3,378,645
3,305,262
3,468,771
3,681,080
3,894,028
3,911,535
4,110,498
4,218,251
4,417,855
4,303,364
4,567,304
4,263,713
5,104,577
4,563,601
4,262,552
4,391,271
4,391,2714,262,5524,563,6015,104,5774,263,7134,567,3044,303,3644,417,8554,218,2514,110,4983,911,5353,894,0283,681,0803,468,7713,305,2623,378,6453,208,7552,593,8872,495,6852,507,9812,752,3382,591,5652,504,1502,517,8012,344,4332,243,1662,161,1642,144,6062,010,8582,014,5951,923,9671,900,2351,780,6531,664,3101,568,1431,559,5861,440,4201,174,0621,280,9471,221,9261,119,5851,078,6711,031,046960,317841,851920,014869,588696,773548,770548,669496,088566,596448,982399,302343,465267,331155,695110,4890000000000310,835322,070355,983221,533196,041185,513219,801195,304205,504194,726217,565
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,571
28,370
81,921
89,620
85,236
83,233
86,175
84,185
80,218
65,435
23,186
23,108
21,960
13,572
30,621
30,280
26,532
25,527
0
29,634
30,903
0
0
0030,90329,634025,52726,53230,28030,62113,57221,96023,10823,18665,43580,21884,18586,17583,23385,23689,62081,92128,37030,57100000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,222,312
Cost of Revenue-4,604,083
Gross Profit3,618,2283,618,228
 
Operating Income (+$)
Gross Profit3,618,228
Operating Expense-7,354,059
Operating Income868,253-3,735,830
 
Operating Expense (+$)
Research Development184,629
Selling General Administrative2,184,549
Selling And Marketing Expenses0
Operating Expense7,354,0592,369,178
 
Net Interest Income (+$)
Interest Income54,642
Interest Expense-35,853
Other Finance Cost-2,034
Net Interest Income16,755
 
Pretax Income (+$)
Operating Income868,253
Net Interest Income16,755
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,095,364868,253
EBIT - interestExpense = -35,853
986,707
1,022,560
Interest Expense35,853
Earnings Before Interest and Taxes (EBIT)01,131,216
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,095,364
Tax Provision-126,658
Net Income From Continuing Ops968,706968,706
Net Income986,707
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-16,755
 

Technical Analysis of Tianjin Zhongxin Pharmaceutical Group Corp Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The general trend of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tianjin Zhongxin Pharmaceutical Group Corp Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 36.27 < 36.36 < 36.56.

The bearish price targets are: 31.17 > 31.05 > 27.53.

Tweet this
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current macd is 1.03514406.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tianjin Zhongxin Pharmaceutical Group Corp Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Tianjin Zhongxin Pharmaceutical Group Corp Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current adx is 28.60.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Tianjin Zhongxin Pharmaceutical Group Corp Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current sar is 31.99.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current rsi is 65.33. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Relative Strength Index (RSI) ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tianjin Zhongxin Pharmaceutical Group Corp Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Stochastic Oscillator ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current cci is 110.04.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Commodity Channel Index (CCI) ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current cmo is 36.54.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Chande Momentum Oscillator (CMO) ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current willr is -19.97063142.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Williams %R ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current atr is 1.11930575.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Average True Range (ATR) ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current obv is -49,632,106.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily On-Balance Volume (OBV) ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tianjin Zhongxin Pharmaceutical Group Corp Ltd. The current mfi is 84.56.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Money Flow Index (MFI) ChartTianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tianjin Zhongxin Pharmaceutical Group Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.327
Ma 20Greater thanMa 5030.383
Ma 50Greater thanMa 10029.540
Ma 100Greater thanMa 20031.436
OpenGreater thanClose32.900
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tianjin Zhongxin Pharmaceutical Group Corp Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tianjin Zhongxin Pharmaceutical Group Corp Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tianjin Zhongxin Pharmaceutical Group Corp Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tianjin Zhongxin Pharmaceutical Group Corp Ltd

I send you an email if I find something interesting about Tianjin Zhongxin Pharmaceutical Group Corp Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

Receive notifications about Tianjin Zhongxin Pharmaceutical Group Corp Ltd in your mailbox!